Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q3-2022 Healthcare Services Private Equity Update

Skip to the end of the Expertise Menu

Q3-2022 Healthcare Services Private Equity Update

Healthcare PE activity displayed impressive resiliency in Q3-22. Healthcare services are perceived as acyclical, as payors and the nondiscretionary behavior of healthcare somewhat insulate PPMs and other providers from radical changes in consumer spending. However, transaction volume and capital invested in Q3-22 continued to decline. Private equity firms still hold an abundant amount of capital, but velocity in which funds are deploying capital has slowed.

PE exits have also fallen off 2021 highs, owing part to rewarding and eager IPO markets and competition from SPACs. Heightened deal volume in 2021 was also driven by fears of a long-term increase in capital gains which led investors to exit portfolios at an elevated pace. However, platforms that have displayed both clinical and operational excellence are still being rewarded in the market through competitive processes and buyers still willing to give credit for various PF EBITDA adjustments.

Staffing shortages have also pinched most healthcare services organizations, consequently increasing costs, shrinking margins, and debilitating growth. Furthermore, valuation multiples have started to plateau or reverted to 2019 levels but have still displayed incredible resiliency compared to its CPG and technology counterparts.

Healthcare PE investors remain cautiously optimistic that deal activity in the lower/middle market will remain stable despite macro headwinds.

To print and download the full Private Equity report, please click below…

[holo_button icon=”/wp-content/uploads/2022/10/Q3-2022-Private-Equity-Newsletter.pdf” link=”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]


Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.